Hyaluronan-Coated Culture Carrier for Stem Cell Expansion

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

Current methods for culturing undifferentiated cells, such as stem cells, in regenerative medicine face challenges as they often require feeder cells that can introduce infectious agents, and existing extracellular matrix components either fail to maintain undifferentiated states or induce differentiation, leading to inconsistent results.

Innovation Solution

A method involving a culture carrier with a surface coated with a non-proteinaceous extracellular matrix component, specifically hyaluronan, is used to culture undifferentiated cells, preserving their proliferation and differentiation potential by simulating an in vivo dormant state.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If feeder cells are used to culture undifferentiated cells, then cell propagation is enabled, but infectious agents may infect the recipient

Engineering Contradiction:

Improvecell propagationVSAvoidinfectious agents

Core Design Contradiction:

ProductivityVSObject-affected harmful factors

Solution Approach 1:

The patent removes feeder cells from the culture system entirely, extracting the harmful element while maintaining cell propagation capability through alternative means (ECM coatings and defined media compositions)

Inventive Principle:

Principle #2Taking out (Extraction)

Solution Approach 2:

The patent introduces intermediary substances including extracellular matrix proteins (laminin, collagen IV), growth factors (FGF, EGF, PDGF), and defined media compositions that mediate cell propagation without requiring feeder cells, thereby eliminating the risk of infectious agents

Inventive Principle:

Principle #24Intermediary (Mediator)

2Ease of operation

If ECM components such as laminin and collagen are used to replace feeder cells, then cell culture without feeder cells is achieved, but differentiation potential is lost

Engineering Contradiction:

Improvefeeder cell-free cultureVSAvoidundifferentiated state

Core Design Contradiction:

Ease of operationVSStability of the object's composition

Solution Approach 1:

The patent modifies the chemical and physical parameters of the culture environment by using defined media compositions with specific growth factors, ECM protein coatings at optimized concentrations, and controlled culture conditions that maintain cells in an undifferentiated state while enabling feeder cell-free propagation

Inventive Principle:

Principle #35Parameter changes

3Ease of operation

If different ECM components are used to maintain undifferentiated cells, then feeder cell-free culture is achieved, but inconsistent effects on differentiation are observed

Engineering Contradiction:

Improvefeeder cell-free cultureVSAvoiddifferentiation potential

Core Design Contradiction:

Ease of operationVSReliability

Solution Approach 1:

The patent employs a multi-component system where multiple ECM proteins (laminin, collagen IV), growth factors (FGF, EGF, PDGF), and defined media work together synergistically to achieve reliable maintenance of undifferentiated cells, replacing the inconsistent single-component approaches

Inventive Principle:

Principle #6Universality (Multi-functionality)

Data Source

PatentUS9688956B2Method for preserving proliferation and differentiation potential of mesenchymal stem cells

Publication Date: 2017.06.27 NAT CHENG KUNG UNIV

AI summary

A method for preserving proliferation and differentiation potential of undifferentiated cells, has steps of providing a culture carrier having a surface coated with a biological material selected from the group consisting of hyaluronan, chondroitin sulfate, carboxymethyl cellulose, carrageenan, alginate, and chitosan; and inoculating and culturing the undifferentiated cells on the surface in the culture carrier with an appropriate medium, such that the proliferation and differentiation potential of undifferentiated cells are preserved. The method can be used for expanding stem cells in vitro without loss of their replicative ability and differentiation capacity. Therefore, the method according to the present invention is amenable to application in regenerative medicine, tissue engineering, and therapy using umbilical cord blood and other cell sources such as peripheral blood, stem cells, tissue progenitor cells, and tissue cells.